Pfizer’s COVID Vaccine Clears Final Hurdle Before FDA Authorization

The FDA’s advisory panel voted 17-4 to approve Pfizer’s COVID-19 vaccine for use, clearing the way for its authorization and distribution nationwide. After scouring over data during a multi-hour meeting on Thursday, the panel determined the vaccine was safe and voted to recommend approval. Though the panel’s decision is merely an advisory one, the FDA is…
The post Pfizer’s COVID Vaccine Clears Final Hurdle Before FDA Authorization appeared first on The Western